Clinical Trial Update: Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pegylated interferon plus ribavirin for acute hepatitis C when started about six months after infection. The study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Acute Hepatitis C | Phase 4 | Status: COMPLETED